BCL2 and neoplasm: The regulation of pro- and anti-apoptotic proteins in imiquimod treated tumour cells has been well established, with several studies measuring changes to BCL2, MCL1, A20 and Noxa after treatment [13–15, 20, 21, 35, 41].